Lewis Rose

Concepts (48)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Combined Chemotherapy Protocols
3
2004
436
0.160
Why?
Amifostine
2
2004
27
0.140
Why?
Vaginal Neoplasms
1
2011
8
0.120
Why?
Vaginal Smears
1
2011
61
0.120
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2011
33
0.120
Why?
Vagina
1
2011
52
0.120
Why?
Carcinoma, Non-Small-Cell Lung
2
2003
152
0.110
Why?
Lung Neoplasms
2
2003
360
0.100
Why?
Idarubicin
1
2004
8
0.080
Why?
Leukemia, Myeloid, Acute
1
2004
55
0.070
Why?
Deoxycytidine
1
2003
74
0.060
Why?
Transcription Factors
1
2005
381
0.060
Why?
Radiation-Protective Agents
1
2002
27
0.060
Why?
Aged
5
2011
4649
0.050
Why?
Breast Neoplasms
1
2005
886
0.050
Why?
Female
5
2011
9889
0.040
Why?
Middle Aged
4
2005
6027
0.030
Why?
Survival Analysis
2
2004
399
0.030
Why?
Infusions, Intravenous
2
2003
120
0.030
Why?
Drug Administration Schedule
2
2003
239
0.030
Why?
Cervical Intraepithelial Neoplasia
1
2011
19
0.030
Why?
Humans
5
2011
19249
0.030
Why?
Diagnosis, Differential
1
2011
470
0.030
Why?
Male
3
2004
9080
0.020
Why?
GATA3 Transcription Factor
1
2005
9
0.020
Why?
Staining and Labeling
1
2005
60
0.020
Why?
Antineoplastic Agents, Hormonal
1
2005
51
0.020
Why?
Cytoprotection
1
2004
26
0.020
Why?
Bone Marrow
1
2004
51
0.020
Why?
Adult
2
2005
5835
0.020
Why?
Pilot Projects
1
2005
252
0.020
Why?
Logistic Models
1
2005
287
0.020
Why?
Case-Control Studies
1
2005
350
0.020
Why?
Predictive Value of Tests
1
2005
471
0.020
Why?
Immunohistochemistry
1
2005
688
0.020
Why?
Topotecan
1
2003
6
0.020
Why?
Maximum Tolerated Dose
1
2003
58
0.020
Why?
Esophagitis
1
2002
17
0.020
Why?
Carboplatin
1
2002
51
0.020
Why?
Radiation-Sensitizing Agents
1
2002
28
0.020
Why?
Paclitaxel
1
2002
79
0.020
Why?
Esophagus
1
2002
42
0.020
Why?
Radiation Injuries
1
2002
87
0.010
Why?
Acute Disease
1
2002
220
0.010
Why?
Combined Modality Therapy
1
2002
358
0.010
Why?
Survival Rate
1
2002
398
0.010
Why?
Aged, 80 and over
1
2003
1869
0.010
Why?
Treatment Outcome
1
2003
2164
0.010
Why?
Rose's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (48)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_